Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1371studies shown
Showing 951-975 of 1,371
CompletedNCT03573297

A Cariprazine Study in the Prevention of Relapse in Bipolarity I Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Malaysia, Poland, United States, Russian Federation, Serbia, South Korea, Taiwan, Thailand, Ukraine
Sponsor
AbbVie
Condition
Bipolarity
CompletedNCT04191876

Financial Incentives to Improve Medication Adherence

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT03679962

Triple Chronotherapy in Adolescents

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Billings Clinic
Condition
Depression
CompletedNCT01342380

Pioglitazone and Quetiapine XR Pharmacogenetic Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Depression
CompletedNCT01065597

Nonconvulsive Electrotherapy: a Proof-of-concept Trial

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
University of Maryland, College Park
Condition
Depression
CompletedNCT03543410

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Japan, Poland, Russian Federation, Serbia, Slovakia, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Depression
CompletedNCT02600507

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression in bipolarity

This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Russian Federation, Serbia, Ukraine, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
CompletedNCT01881763

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Northwell Health
Condition
Depression
CompletedNCT03049813

Virtual Reality Job Interview Training in Severe Mental Illness

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT02567110

Magnetic Resonance Spectroscopy (MRS) in Midlife Depression

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 35 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
CompletedNCT02188121

Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

This study exists to understand how the medication New holds up over time after the earliest research stage. Researchers are trying to understand what helps the medication New stay useful, realistic, and easier to follow over time.

SchizophreniaOtherFrom 18 Years to 89 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia
CompletedNCT05683431

Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolarity (BRAINS)

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Rush University Medical Center
Condition
Bipolarity
CompletedNCT02558075

Mood Lifters: A Self Help Program

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
Bipolarity
CompletedNCT03423212

Just Do You Program for Young Adults With Serious Mental IIlness

This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 28 Years
Countries
United States
Sponsor
New York University
Condition
Bipolarity
CompletedNCT05601063

Ascertaining Diagnosis Classification With Elicited Speech

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 14 Years to 50 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT02696109

Cornerstone Program for Transition-Age Youth Study Protocol for a Randomized Controlled Trial

This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand how people respond to acceptance and commitment therapy, a talking treatment, in practice and what may need to be adjusted.

BipolarityOtherFrom 17 Years to 18 Years
Countries
United States
Sponsor
New York University
Condition
Bipolarity
CompletedNCT01992393

Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Case Western Reserve University
Condition
Schizophrenia
CompletedNCT03402152

NRX101 Glx Biomarker Validation Study

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Bipolarity
CompletedNCT01880957

PET and MRI Brain Imaging of Bipolarity

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Bipolarity
CompletedNCT03249376

Lumateperone Monotherapy for the Treatment of Depression in bipolarity Conducted Globally

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
CompletedNCT02640950

An Open Label Trial of TMS Therapy for Depression in bipolarity

This study exists to understand whether the medication TMS is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication TMS can give earlier or clearer feedback during care.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Bipolarity
WithdrawnNCT04430959

Candesartan as an Adjunctive Treatment for Depression in bipolarity

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity
CompletedNCT02845440

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
CompletedNCT03156504

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
TerminatedNCT02707276

LFMS: Initial Trial in Geriatric Depression in bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 55 Years to 85 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity